Abdelhafiz Mohammed Abdalla

Department of Pharmaceutical Technology, College of Pharmaceutical Science, Andhra University, Visakhapatnam, India


  • Research Article   
    Lung Cancer Increased Risk with Long Term Use of Angiotensin Converting Enzyme Inhibitors: A Systematic Review
    Author(s): Omer Ibrahim A Omer52753* and Abdelhafiz Mohammed Abdalla52754

    Background: The aim of this study is to investigate the risk of lung cancer linked with the use of Angiotensin- Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARB) and Overall Survival for lung cancer. Methods: By using specific terminologies related to cancer and the inhibitors of ACEIs/ARBs, we searched on several research databases for studies that used to investigate the lung cancer risk associated with patients uses of ACEIs/ARBs. Results: Thirty two studies met the inclusion criteria. In two investigations, individuals with advanced pancreatic cancer (HR=0.52, %CI 0.29-0.88) and non-small cell lung cancer (HR=0.56, %CI 0.33-0.95) had a substantial improvement in Overall Survival (OS). Long-term usage of ACEIs/ARBs was linked to an elevated risk .. Read More»
    DOI: 10.31858/0975-8453.14.2.82-90

    Abstract HTML PDF